BeOne Medicines Ltd. — Director's Dealing 2025

Sep 9, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeOne Medicines Ltd. (ONC)
CIK: 0001651308
Period of Report: 2025-09-05

Reporting Person: Sanders Corazon (Corsee) D. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-05	American Depositary Shares	M	2665	$155.68	Acquired	2665	Direct
2025-09-05	American Depositary Shares	S	2665	$337	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-05	Share Option (Right to Buy)	$11.98	M	34645	Disposed	2032-06-21	Ordinary Shares (34645)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	57226	Direct

Footnotes

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F3: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors (the "Board") or otherwise ceases to serve as a director, unless the Board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.